injectiespuit

Currently, our vaccine pipeline focusses on three disease areas: airborne, mucosal-borne, and vector-borne diseases.

Airborne diseases

Airborne diseases are caused by pathogens that are small enough to be discharged from an infected person via coughing, talking, sneezing, close personal contact or even by laughing.  

ZIP-09

Undisclosed

ZIP-1642

COVID-19

Disease

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

ZIP-10

Undisclosed

Mucosal-borne diseases

Mucosal-borne diseases occur through direct contact with the mucous membranes of the mouth and genitals. They are often spread through skin-to-skin contact such as kissing and sexual intercourse. 

ZIP-11

Undisclosed

Disease

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

ZIP-08

Undisclosed

ZIP-13

Undisclosed

ZIP-14

Undisclosed

ZIP-15

Undisclosed

ZIP-16

Undisclosed

ZIP-17

Undisclosed

ZIP-12

Undisclosed

Vector-borne diseases

Vector-borne diseases are infections transmitted by bites of infected arthropods such as mosquitos, ticks and flies.

Disease

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

ZIP-21

Undisclosed

ZIP-20

Undisclosed

ZIP-19

Undisclosed

ZIP-18

Undisclosed

Our Pipeline

 Address. Legeweg 157C,  B-8020 Oostkamp, Belgium

© 2019 Ziphius Vaccines NV